These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 37240215)

  • 1. Environmental Pollution and the Risk of Developing Metabolic Disorders: Obesity and Diabetes.
    Khalil WJ; Akeblersane M; Khan AS; Moin ASM; Butler AE
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut Microbiota, Endocrine-Disrupting Chemicals, and the Diabetes Epidemic.
    Velmurugan G; Ramprasath T; Gilles M; Swaminathan K; Ramasamy S
    Trends Endocrinol Metab; 2017 Aug; 28(8):612-625. PubMed ID: 28571659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global pollution by organochlorinated endocrine disruptors - possible challenge for mankind at the onset of millennium.
    Langer P
    Endocr Regul; 2015 Jan; 49(1):25-36. PubMed ID: 25687678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistent Organic Pollutants as Risk Factors for Obesity and Diabetes.
    Yang C; Kong APS; Cai Z; Chung ACK
    Curr Diab Rep; 2017 Nov; 17(12):132. PubMed ID: 29098478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Endocrine disruptors and metabolic diseases: a major public health challenge].
    Nalbone G; Cicolella A; Laot-Cabon S
    Sante Publique; 2013; 25(1):45-9. PubMed ID: 23705334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of dioxin and other persistent organic pollutants (POPs) with diabetes: epidemiological evidence and new mechanisms of beta cell dysfunction.
    De Tata V
    Int J Mol Sci; 2014 May; 15(5):7787-811. PubMed ID: 24802877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bisphenol A: Targeting metabolic tissues.
    Chevalier N; Fénichel P
    Rev Endocr Metab Disord; 2015 Dec; 16(4):299-309. PubMed ID: 26820262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Environmental endocrine disruptors: New diabetogens?
    Fénichel P; Chevalier N
    C R Biol; 2017; 340(9-10):446-452. PubMed ID: 28826789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disparities in Environmental Exposures to Endocrine-Disrupting Chemicals and Diabetes Risk in Vulnerable Populations.
    Ruiz D; Becerra M; Jagai JS; Ard K; Sargis RM
    Diabetes Care; 2018 Jan; 41(1):193-205. PubMed ID: 29142003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The emerging role of endocrine disruptors in pathogenesis of insulin resistance: a concept implicating nonalcoholic fatty liver disease.
    Polyzos SA; Kountouras J; Deretzi G; Zavos C; Mantzoros CS
    Curr Mol Med; 2012 Jan; 12(1):68-82. PubMed ID: 22082482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Critical Overview on Endocrine Disruptors in Diabetes Mellitus.
    Hinault C; Caroli-Bosc P; Bost F; Chevalier N
    Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endocrine Aspects of Environmental "Obesogen" Pollutants.
    Nappi F; Barrea L; Di Somma C; Savanelli MC; Muscogiuri G; Orio F; Savastano S
    Int J Environ Res Public Health; 2016 Jul; 13(8):. PubMed ID: 27483295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Environmental Factors as Diabetic Mediators: A Mechanistic Approach.
    Firdous P; Nissar K; Bashir H; Hussain QA; Masoodi SR; Ganai BA
    Curr Diabetes Rev; 2022; 18(9):e301221199656. PubMed ID: 34967298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developmental exposure to endocrine-disrupting chemicals programs for reproductive tract alterations and obesity later in life.
    Newbold RR
    Am J Clin Nutr; 2011 Dec; 94(6 Suppl):1939S-1942S. PubMed ID: 22089436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endocrine disruptive compounds and cardio-metabolic risk factors in children.
    Khalil N; Chen A; Lee M
    Curr Opin Pharmacol; 2014 Dec; 19():120-4. PubMed ID: 25306432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Endocrine disruptors: A missing link in the pandemy of type 2 diabetes and obesity?].
    Chevalier N; Fénichel P
    Presse Med; 2016 Jan; 45(1):88-97. PubMed ID: 26655260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring the Effects of Metabolism-Disrupting Chemicals on Pancreatic α-Cell Viability, Gene Expression and Function: A Screening Testing Approach.
    Al-Abdulla R; Ferrero H; Boronat-Belda T; Soriano S; Quesada I; Alonso-Magdalena P
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Firm human evidence on harms of endocrine-disrupting chemicals was unlikely to be obtainable for methodological reasons.
    Lee DH; Jacobs DR
    J Clin Epidemiol; 2019 Mar; 107():107-115. PubMed ID: 30543909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endocrine Disrupting Chemical Induced "Pollution of Metabolic Pathways": A Case of Shifting Paradigms With Implications for Vascular Diseases.
    Janardhanan R
    Curr Drug Targets; 2018; 19(9):1024-1037. PubMed ID: 29756578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistent Organic Pollutants and Concern Over the Link with Insulin Resistance Related Metabolic Diseases.
    Mostafalou S
    Rev Environ Contam Toxicol; 2016; 238():69-89. PubMed ID: 26670033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.